Live Event: Nurses at the forefront of change


    No event(s) found.

Upcoming Events

COVID-19 News

Johnson & Johnson vaccine: EU regulator says blood clot very rare side effect

The EU’s drugs regulator has said that blood clots should be listed as a “very rare” side effect of the Johnson & Johnson Covid-19 vaccine.

The European Medicines Agency said in a statement that it had found a “possible link” between the jab and clots.

But it added that the benefits of the Covid-19 vaccine outweighed the risks.

Out of more than seven million people who have received the jab in the US, eight people developed rare blood clots, including one person who died.

Earlier this month, the EMA made the same recommendation for the Covid-19 vaccine produced by Oxford-AstraZeneca.

That recommendation, made on 7 April, came after 86 out of 25 million Europeans administered with the jab developed the unusual blood clots.

The UK then stopped administering the AstraZeneca vaccine to people under 30 years old.

Read the full article at: BBC

Add Your Heading Text Here

Add Your Heading Text Here

أبجد هوز حطي كلمن سعفص قرشت ثخذ ضظغ

Meet the Innovator

Speaker Name

Speaker Position

أبجد هوز حطي كلمن سعفص قرشت ثخذ ضظغ

Innovator Name

Innovation Name


تعرف على المبدعين


Unheeded Warnings Mitigating the Impact of Climate Change on Communicable Diseases

Jeremy Hess, Rachel Lowe, Muna Al Maslamani, Laura-Lee Boodram, Anna Stewart Ibarra, Judith Wasserheit

With the emergent threat of COVID-19, this report focuses on threatening diseases that are a by-product of climate change and what type of policy measures should be intact to deal with this head-on.


Add Your Heading Text Here

أبجد هوز حطي كلمن سعفص قرشت ثخذ ضظغ

أبجد هوز حطي كلمن سعفص قرشت ثخذ ضظغ